Low-dose heparin for the prevention of post-ERCP pancreatitis: A randomized placebo-controlled trial

Surgical Endoscopy and Other Interventional Techniques

Volumn 22, Issue 9, 2008, Pages 1971-1976

  Barkay, O ^a   Niv, E ^a   Santo, E ^a   Bruck, R ^a   Hallak, A ^a   Konikoff, F M ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

Clinical papers trials research; Complications; Endoscopic retrograde cholangiopancreatography; ERCP; Pancreatic

Indexed keywords

AMYLASE; HEPARIN; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VATER PAPILLA;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; AMYLASES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HEPARIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PANCREATITIS; TREATMENT FAILURE;

EID: 51349114338     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-007-9738-2     Document Type: Article

References (35)

1. ML Freeman DB Nelson S Sherman GB Haber ME Herman PJ Dorsher JP Moore MB Fennerty ME Ryan MJ Shaw JD Lande AM Pheley 1996 Complications of endoscopic biliary sphincterotomy N Engl J Med 335 909 918
2. J Baille 1994 Complications of endoscopy Endoscopy 26 185 203
3. K Huibregtse 1996 Complications of endoscopic sphincterotomy and their prevention N Engl J Med 335 961 963
4. C Niederau U Pohlmann H Lubke L Thomas 1994 Prophylactic antibiotic treatment on therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study Gastrointest Endosc 40 533 537
5. M Guelrud S Mendoza L Viera D Guelrud 1991 Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis Gastrointest Endosc 36 44 47
6. Z Tulassay J Papp 1991 The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography Gastrointest Endosc 37 48 50
7. GR Weiner JE Geenen WJ Hogan MF Catalano 1995 Use of corticosteroids in the prevention of post-ERCP pancreatitis Gastrointest Endosc 42 579 583
8. GD De Palma C Catanzano 1999 Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of controlled prospective study Am J Gastroenterol 94 982 985
9. B Murray R Carter C Imrie S Evans C O'Suilleabhain 2003 Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 1786 1791
10. F Prat J Amaris B Ducot M Bocquentin J Fritsch AD Choury G Pelletrier C Buffet 2002 Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study Gastrointest Endoscopy 56 202 208
11. M Moreto M Zaballa I Casado O Merino M Rueda K Ramirez R Urcelay A Baranda 2003 Transdermal glyceryl trinitrate for prevention of post- ERCP pancreatitis: a randomized double-blind trial Gastrointest Endosc 57 1 7
12. G Cavallini A Tittobello L Frulloni E Masci A Mariani V DiFrancesco 1996 Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangio-pancreatography N Engl J Med 335 919 923
13. J Deviere O Le Moine JL Van Laethem P Eisendrath A Ghilain N Severs M Cohard 2001 Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangio-pancreatography Gastroenterology 120 498 505
14. Z Tulassay Z Döbrönte L Prónai T Zágoni L Juhász 1998 Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography Aliment Pharmacol Ther 12 1109 1112
15. KC Thomopoulos NA Pagoni KA Vagenas VG Margaritis GI Theocharis VN Nikolopoulou 2006 Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis Gastrointest Endosc 64 726 731
16. PR Tarnasky YY Palesch JT Cunningham PD Mauldin PB Cotton RH Hawes 1998 Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction Gastroenterology 115 1518 1524
17. A Smithline W Silverman D Rogers R Nisi M Wiersema P Jamidar R Hawes G Lehman 1993 Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients Gastrointest Endosc 39 652 657
18. A Fazel A Quadri MF Catalano SM Meyerson JE Geenen 2003 Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study Gastrointest Endosc 57 291 294
19. S Sherman EL Bucksot E Esber J Pezzi K Gottlieb G Lehman 1995 Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy induced pancreatitis? Randomized prospective study (abstract) Am J Gastroenterol 90 241
20. A Gabryelewicz S Kosidlo J Prokopowicz K Prokopowicz 1986 Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats? Hepatogastroenterology 33 79 92
21. S Kosidlo A Gabryelewicz J Prokopowicz K Prokopowicz 1986 Pancreatic proteolytic and inhibitory activity during acute experimental pancreatitis in rats with reference to heparin treatment (in Polish with English abstract) Mater Med Pol 18 136 143
22. P Toulon G Chadeuf JL Bouillot J Amiral M Cambillau Y Sultan M Aliach 1991 Involvement of heparin cofactor II in chymotrypsin neutralization and in pancreatic-proteinase-antiproteinase interaction during acute pancreatitis in man Eur J Clin Invest 21 303 309
23. WK Bleeker J Agterberg G Rigter CE Hack JV Gool 1992 Protective effect of antithrombin III in acute experimental pancreatitis in rats Dig Dis Sci 37 280 285
24. M Dobosz S Hac L Mionskowska S Dobrowolski Z Wajda 1997 Microcirculatory disturbances of the pancreas in caerulein-induced acute pancreatitis in rats with reference to L-arginine, heparin, and procaine treatment Pharmacol Res 36 123 128
25. A Salas M Sans A Soriano JC Reverter DC Anderson JM Pique J Panes 2000 Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism Gut 47 88 96
26. R Leever J Robin S Hoult CP Page 2000 The effects of heparin and related molecules upon the adhesion of human polymorphnuclear leukocytes to vascular endothelium in vitro Br J Pharmacol 129 533 540
27. A Koenig K Norgard-Sumnicht R Linhardt A Varki 1998 Differential interactions of heparin and heparin sulfate glycosaminoglycans with the selectins: implications for the use of unfractionated and low-molecular-weight heparins as therapeutic agents J Clin Invest 101 877 889
28. SD Bowler SM Smith PS Lavercombe 1993 Heparin inhibits the immediate response to antigen in the skin and lung of allergic subjects Am Rev Respir Dis 147 160 163
29. T Rabenstein S Roggenbuck B Framke P Martus B Fisher G Nusko S Muehldorfer J Hochberger C Ell EG Hahn HT Schneider 2002 Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 55 476 483
30. T Rabenstein B Fischer V Wiessner H Schmidt M Radespiel-Troger J Hochberger S Muehldorfer G Nusko H Meissmann J Scholmerich HJ Schulz H Schonekas EG Hahn HT Schneider 2004 Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis Gastrointest Endos 59 606 613
31. PB Cotton G Lehman JA Vennes JE Geenen RCG Russell WC Meyers C Liguory N Nickl 1991 Endoscopic sphincterotomy complications and their management: an attempt at consensus Gastrointest Endosc 37 383 391
32. JH Ranson 1979 The timing of biliary surgery in acute pancreatitis Ann Surg 189 654 663
33. EJ Balthazar JH Ranson DP Naidich AS Megibow R Caccavale MM Cooper 1985 Acute pancreatitis: prognostic value of CT Radiology 158 767 772
34. JW Estes 1980 Clinical pharmacokinetics of heparin Clin Pharmacokinet 5 204 220
35. ML Freeman 2002 Adverse outcomes of ERCP Gastrointest Endosc 56 S273 S282